1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy ForumArchived Questions and Answers
This Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
Hi, I am 18 weeks pregnant and I've just been diagnosed with melanoma. I had a mole removed on my right shoulder, and the biopsy revealed a tumor 1.2 mm Breslow. Is it safe to do the Sentinnel Lymph Node Test in my condition? I have also done the second surgery to remove more tissue from around the initial mole. Thank you. Kind regards, Florina
The following information should not replace the assessment and advice you have been receiving from your physician (cancer specialist, obstetrician, or any other healthcare provider). It is offered for your information only. Consult your physician.
A sentinel lymph node biopsy is a small surgical procedure that takes out lymph node tissue to look for cancer. A sentinel node biopsy is used to see if the melanoma has spread from the original cancer site. In general, surgery is not contraindicated for pregnancy and the use of general anesthesia does not increase the risk for birth defects above the baseline risk of 1-3%. The doctor will inject a dye, usually Isosulfan Blue. At 18 weeks of gestation, there is no risk of malformations from this dye.